mRNA is an exciting new technology that holds great promise to improve prevention and treatment in many different disease areas.
We want to connect our immunology community to this growing field, empowering you to generate ideas for your research, start conversations and seek new collaborations.
Join us on Wednesday 24 April at 11:00 – 12:00 BST to discover how mRNA vaccines can stimulate the immune system to target cancer and the latest progress in their clinical application.
This free webinar is the second of a two-part series on mRNA technologies hosted by the British Society for Immunology and made possible through an educational grant provided by Moderna. The first webinar ‘Understanding immune responses to therapeutic mRNA technologies’ will take place on Tuesday 16 April – find out more and register.
Speakers
- Dr Pippa Corrie, Cambridge University Hospitals NHS Foundation Trust, UK
- Professor Robin Shattock, Imperial College London, UK
Chair
- Professor Colin Dayan, Cardiff University, UK
Content summary
Our expert speakers will present their work in the following areas before the session opens up for a discussion with questions from the audience.
- Overview of mRNA vaccines: a brief introduction to mRNA vaccines, how they differ from traditional vaccines and how they work to stimulate the immune system against cancer cells
- Advancements in cancer immunotherapy: focusing on the role of mRNA vaccines in harnessing the immune system to target and eliminate cancer cells, including discussion of personalised cancer vaccines
- Clinical outcomes: the latest data on patient responses to mRNA vaccination, an update on current clinical trials for mRNA in cancer and the ongoing challenges for translating mRNA vaccination strategies into clinical practice
- Patient impact: information about patients who have participated in mRNA vaccine trials or received mRNA-based cancer treatments and a discussion of the role of patient engagement in advancing cancer research and treatment options
Registration
This is a free webinar aimed at clinicians, researchers and industry professionals with an interest in the clinical applications of mRNA technology in cancer treatment. Book your free place here.
CPD
This webinar is approved for one Continuing Professional Development (CPD) credit from the Royal College of Pathologists.
The activities associated with this project are made possible through an educational grant provided by Moderna. Moderna has not and will not direct or influence the content of the project or any of its activities.
